ST STOK $31.20 ▼ -4.27% Should I Buy Stoke Therapeutics (STOK)? Finance YouTuber Analysis
VERDICT: BUY 0/100
Get weekly updates on this stock
“The YouTuber identifies Stoke Therapeutics as a biotech company focused on rare genetic diseases, with a lead drug for Dravet syndrome in final…”
Financials
Reported figures · last 5 yearsCall record — STOK
1 CALLS · 1 BUY / 0 SELL / 0 WATCHCreate a free account to see every call — who, when, at what price.
Each call is dated, linked to the source video, and graded. Free accounts see the full record.
FAQ
Should I buy Stoke Therapeutics?
1 finance YouTubers analysed Stoke Therapeutics with qualified reasoning — consensus: Buy, average analysis quality 65/100. This is not financial advice; review the individual analyses and sources above.
Are finance YouTubers bullish or bearish on Stoke Therapeutics?
Among the channels covering Stoke Therapeutics, 1 are buying and 0 are selling or avoiding — overall Buy.
What price target do YouTubers give Stoke Therapeutics?
The price targets mentioned for Stoke Therapeutics range 28. Targets are the YouTubers' own; not a guarantee.
How do you decide what to include for Stoke Therapeutics?
Only qualified analyses count: a clear buy/sell stance on Stoke Therapeutics with real reasoning (valuation, fundamentals, a catalyst or a chart setup). Passing mentions are excluded.